Humacyte Days Payables Outstanding from 2010 to 2024

HUMAW Stock  USD 1.50  0.09  5.66%   
Humacyte Days Payables Outstanding yearly trend continues to be fairly stable with very little volatility. Days Payables Outstanding will likely drop to 29.40 in 2024. During the period from 2010 to 2024, Humacyte Days Payables Outstanding regression line of quarterly data had mean square error of 16.3 M and geometric mean of  34.04. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
30.9451339
Current Value
29.4
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Humacyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humacyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 1.1 M or Selling General Administrative of 21.1 M, as well as many indicators such as Price To Sales Ratio of 96.95, Dividend Yield of 0.0 or PTB Ratio of 22.77. Humacyte financial statements analysis is a perfect complement when working with Humacyte Valuation or Volatility modules.
  
Check out the analysis of Humacyte Correlation against competitors.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Latest Humacyte's Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of Humacyte over the last few years. It is Humacyte's Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Humacyte's overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Pretty Stable
   Days Payables Outstanding   
       Timeline  

Humacyte Days Payables Outstanding Regression Statistics

Arithmetic Mean1,066
Geometric Mean34.04
Coefficient Of Variation377.25
Mean Deviation1,938
Median15.80
Standard Deviation4,020
Sample Variance16.2M
Range15.6K
R-Value0.25
Mean Square Error16.3M
R-Squared0.06
Significance0.37
Slope225.13
Total Sum of Squares226.3M

Humacyte Days Payables Outstanding History

2024 29.4
2023 30.95
2022 70.52
202115.6 K
2020 98.44

About Humacyte Financial Statements

Humacyte investors use historical fundamental indicators, such as Humacyte's Days Payables Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Humacyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Payables Outstanding 30.95  29.40 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.